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In this era of personalized medicine Pathology plays a 
pivotal role and pathologists are at the forefront of 
establishing a correct diagnosis, on the basis of which 
further management of any disease is carried out.  Infect 
the glorification of modern medicine and understanding of 
human body owes a lot to advances in pathology.  A 
practicing physician or a surgeon is stranded without the 
help of a diagnostic pathology laboratory and guidelines 
from pathologist. Clinician suspects a disease and 
advises a battery of laboratory tests encompassing all the 
differential diagnosis and quite often, the confirmation 
requires a microscopic examination or more sophisticated 
tests involving molecular or genetic studies.   It is believed 
that 70% of clinical decisions are based upon laboratory 
tests. 
Collaboration between the pathologist and clinician has 
been found to be indispensable in improving the quality of 
patient care especially in, but not limited to, the areas of 
cancer management and care.1 Knowledge about the 
sample collection, the right container used and proper 
documentation can minimize the pre-analytic errors. 
Laboratory request form is the first contact between the 
patient and laboratory and inadequately completed 
laboratory request forms or illegible clinical information 
provided limits pathologists advice to clinician and may 
contribute to medical errors. Majority of laboratory errors 
occur in pre-analytic phase of laboratory workflow and 
inadequately completed forms have been described as a 
contributory pre-analytic error.2   Awareness about the 
limitations and interpretation of different test results is an 
essential component of patient care. 
Despite all precautionary measures “Zero lab error” is a 
Utopian target for any lab however only 15% of errors 
occur in Analytic phase. 3 Availability of relevant clinical 
history, imaging results, supportive laboratory results and 
procedural details contribute a lot towards establishing a 
correct cytological or histopathological diagnosis. In a 
study titled as “Clinicians are from Mars and pathologists 
are from Venus” it is highlighted that a  communication 
gap exists between pathologists and surgeons and 
surgeons misunderstood pathologists report 30% of the 
time.4  The practice of deliberately hiding the relevant 
clinical details from pathologist can lead to detrimental 
consequences for the patient. 
Seeking advice of microbiologist is of immense value in 
selecting the best arsenal to combat infectious diseases 
and to minimize hospital acquired infections by utilizing 
guidelines of hospital infection control committee. 
Similarly, a hematologist can provide the best advice in 
conditions like DIC and other life threatening 
hematological disorders. When to transfuse and which 
component of blood is required for the particular patient 
falls under the domain of Blood Transfusion specialist or a 
hematologist and a coordinated effort is of utmost benefit 
for the patient.    
To shorten the communication gap between the 
pathologist and clinician, various strategies have been 
suggested. Most convenient is to share the patient’s 
clinical details on telephone or a junior doctor can visit the 
laboratory in a hospital setting and exchange clinical 
details. Interdepartmental meetings and clinico-
pathological conferences are quite useful in this regard. 
Multidisciplinary teams involving a pathologist, radiologist 
and other clinical specialties also add quality to diagnosis 
and best patient management decisions. 
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Diabetes Mellitus is a chronic metabolic disorder 
characterized by persistent hyperglycemia and disorders 
of carbohydrate, protein and lipid metabolism.1 It is 
expected that by the year 2030, about 552 million people 
globally will be affected from diabetes mellitus.2 If not well 
controlled, diabetes mellitus leads to both microvascular 
and macrovascular complications.2 Diabetic mellitus is the 
most common cause of diabetes nephropathy that has a 
momentous impact on quality of life and survival of the 
patient.1 It is estimated that about 40 % of type I and type 
II diabetes mellitus develop diabetic kidney disease.2 If 
not timely diagnosed and properly treated, diabetic 
nephropathy eventually leads to End stage renal disease 
that requires dialysis or renal transplantation. Multiple 
serum and urinary biomarkers are used to diagnose 
diabetic nephropathy before it is clinically evident.2 
Urinary microalbumin has been used as a clinical 
biomarker of diabetic kidney disease since 1982.4 It is 
used to screen both type I and type II diabetes mellitus.5 
Microalbuminuria results when albumin crosses 
glomerular filtration barrier due to ultrastructural changes 
in endothelial glycocalyx.6 Microalbuminuria also 
represents a marker of systemic endothelial dysfunction 
with increased risk of cardiovascular and cerebral insults 
in patients with diabetes mellitus.7 
In addition to glomerular injury, newer biomarkers of 
tubular, vascular, inflammation, podocytes and oxidative 
stress have been verified in some patients that detect 
diabetic nephropathy much earlier than 
microalbuminuria.3 Usefulness of these biomarkers is still 
debatable in research due to limited studies performed 
and requires further validation.3 Microalbuminuria even 
disputed as biomarker of early diabetic nephropathy, is 
still considered as an important screening test to detect 
glomerular and tubular injury in diabetic population.3 
American Diabetes Association guidelines recommend 
initial assessment of urinary albumin excretion in type I 
diabetes mellitus who have had diabetes for at least five 
years and in all patients with type II diabetes mellitus at 
the time of presentation and during pregnancy.8 All 
diabetic patients with negative screening test for 
microalbuminuria should be assessed for kidney functions 
on annual basis.9 
Microalbuminuria (although a misnomer term) is detection 
of small quantity of albumin (and not small-size albumin) 
in the urine i.e. 30-300 mg/24 hours or 20 to 200 µg/min 
in the absence of clinical proteinurea as measured by 
standard analytical methods.7 More appropriate term for 
microalbuminuria is paucialbuminuria or albumin excretion 
rate.10 
Normal urinary albumin excretion is less than 30 mg/24 
hours (20ug/min). This small amount is not detectable by 
